Replies to post #78193 on Biotech Values

[DewDiligence]

NGVN: As for the share price jump, it seems to be loosely correlated with the ex-CEOs comments. Notice that he's basically selling a "we'll still succeed" storyline.

What about the ex-CEO’s confusing the number of completed patients in Nov 2008 with the number of events? How can this not be intentional misdirection?